Case report reveals persistent bacteraemia in a lung transplant recipient, highlighting the need for therapy reassessment.
Lung transplant recipients are at risk of opportunistic infections because of immunosuppression. We report a case of Burkholderia vietnamiensis bacteraemia that occurred 3 months after bilateral lung transplantation for diffuse panbronchiolitis. Persistent bacteraemia developed despite apparent in vitro susceptibility to meropenem. Therefore, antimicrobial therapy was reassessed and modified according to the clinical course rather than susceptibility results alone, which resulted in clearance of bacteraemia. The patient recovered without recurrence during a short‐term follow‐up. This case highlights an important clinical lesson that antimicrobial susceptibility testing may not reliably predict the treatment response in Burkholderia cepacia complex infections after lung transplantation. Early reassessment of therapy should be considered when bacteraemia persists despite apparently active antimicrobial agents.
No takes yet. Share an insight, caveat, or question.
Ryo et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: